Breast Radiology Reporting - 1st STU ballot - Local Development build (v0.2.0). See the Directory of published versions
Source view
<ValueSet xmlns="http://hl7.org/fhir"> <id value="BiRadsAssessmentCategoriesVS"/> <text> <status value="generated"/> <div xmlns="http://www.w3.org/1999/xhtml"><h2>BiRads(r) Assessment Category ValueSet</h2><div><p>BiRads(r) Assessment Category value set.</p> </div><ul><li>Include these codes as defined in <a href="CodeSystem-BiRadsAssessmentCategoriesCS.html"><code>http://hl7.org/fhir/us/breast-radiology/CodeSystem/BiRadsAssessmentCategoriesCS</code></a><table class="none"><tr><td style="white-space:nowrap"><b>Code</b></td><td><b>Display</b></td></tr><tr><td><a href="CodeSystem-BiRadsAssessmentCategoriesCS.html#BiRadsAssessmentCategoriesCS-Category0">Category0</a></td><td>Category 0 (Incomplete)</td><td>Need additional Imaging Evaluation and/or prior Mammograms <br/>for comparison. <br/>Recall for additional imaging and/or comparison with <br/>prior examination(s) <br/>[Breast Imaging Reporting and Data System—Mammography, Fifth Edition] <br/><br/>Valid for the following modalities: MG US MRI NM.</td></tr><tr><td><a href="CodeSystem-BiRadsAssessmentCategoriesCS.html#BiRadsAssessmentCategoriesCS-Category2">Category2</a></td><td>Category 2 (Benign)</td><td>This is a normal assessment. <br/>Benign refers to a condition, tumor, or growth that <br/>is not cancerous. <br/>This means that it does not spread to other parts <br/>of the body. <br/>It does not invade nearby tissue. <br/>Essentially 0% likelihood of malignancy. <br/>[Breast Imaging Reporting and Data System—Mammography, Fifth Edition] <br/><br/>Valid for the following modalities: MG US MRI NM.</td></tr><tr><td><a href="CodeSystem-BiRadsAssessmentCategoriesCS.html#BiRadsAssessmentCategoriesCS-Category3">Category3</a></td><td>Category 3 (Probably Benign)</td><td>A finding assessed using this category should have <br/>a <= 2% likelihood of malignancy, <br/>but greater than the essentially 0% likelihood of <br/>malignancy of a characteristically <br/>benign finding. <br/>A probably benign finding is not expected to change <br/>over the suggested period of <br/>imaging surveillance, but the interpreting physician <br/>prefers to establish stability <br/>of the finding before recommending management limited <br/>to routine mammography screening. <br/>Six month follow-up and/or <br/>surveillance mammography is recommended. <br/>[Breast Imaging Reporting and Data System—Mammography, Fifth Edition] <br/><br/>Valid for the following modalities: MG US MRI NM.</td></tr><tr><td><a href="CodeSystem-BiRadsAssessmentCategoriesCS.html#BiRadsAssessmentCategoriesCS-Category4">Category4</a></td><td>Category 4 (Suspicious)</td><td>This category is reserved for findings that do not <br/>have the classic appearance of <br/>malignancy but are sufficiently suspicious to justify <br/>a recommendation for biopsy. <br/>There is a 2% likelihood of malignancy (cancer). <br/>Almost all recommendations for breast interventional <br/>procedures will come from assessments <br/>made using <br/>this category. <br/>[Breast Imaging Reporting and Data System—Mammography, Fifth Edition] <br/><br/>Valid for the following modalities: MG US MRI NM.</td></tr><tr><td><a href="CodeSystem-BiRadsAssessmentCategoriesCS.html#BiRadsAssessmentCategoriesCS-Category4A">Category4A</a></td><td>Category 4A (Low suspicion)</td><td>Low suspicion for malignancy. <br/>A malignant finding is not suspected. <br/>A biopsy or other test will likely still be performed <br/>in order to determine. <br/>Tissue diagnosis may be recommended. <br/>Six month follow-up and/or surveillance mammography <br/>is recommended. <br/>Likelihood of malignancy is > 2% to <= 10% likelihood <br/>of malignancy. <br/>[Breast Imaging Reporting and Data System—Mammography, Fifth Edition] <br/><br/>Valid for the following modalities: MG US MRI NM.</td></tr><tr><td><a href="CodeSystem-BiRadsAssessmentCategoriesCS.html#BiRadsAssessmentCategoriesCS-Category4B">Category4B</a></td><td>Category 4B (Moderate suspicion)</td><td>Category 4B: Moderate suspicion for malignancy. <br/>It warrants radiologic and pathologic correlation <br/>after tissue diagnosis. <br/>Likelihood of malignancy is > 10% to <= 50% likelihood <br/>of <br/>malignancy. <br/>[Breast Imaging Reporting and Data System—Mammography, Fifth Edition] <br/><br/>Valid for the following modalities: MG US MRI NM.</td></tr><tr><td><a href="CodeSystem-BiRadsAssessmentCategoriesCS.html#BiRadsAssessmentCategoriesCS-Category4C">Category4C</a></td><td>Category 4C (High suspicion)</td><td>Category 4C: High suspicion for <br/>malignancy. <br/>Includes findings that have a high suspicion of malignancy <br/>but that are not highly <br/>suggestive of malignancy (category 5). <br/>Tissue Diagnosis is highly recommended. <br/>Range for likelihood of malignancy is > 50% to < <br/>95% likelihood of malignancy. <br/>It is more likely malignant versus benign. <br/>[Breast Imaging Reporting and Data System—Mammography, Fifth Edition] <br/><br/>Valid for the following modalities: MG US MRI NM.</td></tr><tr><td><a href="CodeSystem-BiRadsAssessmentCategoriesCS.html#BiRadsAssessmentCategoriesCS-Category5">Category5</a></td><td>Category 5 (Highly Suggestive of Malignancy)</td><td>Highly Suggestive of Malignancy. <br/>Almost certainly predictive of breast cancer with <br/>a <br/>value of at least 95%. <br/>Tissue Diagnosis is highly recommended or required. <br/>[Breast Imaging Reporting and Data System—Mammography, Fifth Edition] <br/><br/>Valid for the following modalities: MG US MRI NM.</td></tr><tr><td><a href="CodeSystem-BiRadsAssessmentCategoriesCS.html#BiRadsAssessmentCategoriesCS-Category6">Category6</a></td><td>Category 6 (Known Biopsy-Proven Malignancy)</td><td>Known Biopsy-Proven Malignancy. <br/>Surgical excision when clinically <br/>appropriate. <br/>This category is only used for findings on a mammogram <br/>that have already been shown to be cancer by a previous <br/>biopsy. <br/>Mammograms may be used in this way to see how well <br/>the cancer is responding to treatment. <br/>[Breast Imaging Reporting and Data System—Mammography, Fifth Edition] <br/><br/>Valid for the following modalities: MG US MRI NM.</td></tr></table></li></ul></div> </text> <url value="http://hl7.org/fhir/us/breast-radiology/ValueSet/BiRadsAssessmentCategoriesVS"/> <version value="0.2.0"/> <name value="BiRadsAssessmentCategoriesVS"/> <title value="BiRads(r) Assessment Category ValueSet"/> <status value="draft"/> <date value="2019-11-01T00:00:00+00:00"/> <publisher value="Hl7 - Clinical Interoperability Council"/> <contact> <telecom> <system value="url"/> <value value="http://hl7.org/Special/committees/cic"/> </telecom> </contact> <description value="BiRads(r) Assessment Category value set."/> <jurisdiction> <coding> <system value="http://unstats.un.org/unsd/methods/m49/m49.htm"/> <code value="001"/> </coding> </jurisdiction> <compose> <include> <system value="http://hl7.org/fhir/us/breast-radiology/CodeSystem/BiRadsAssessmentCategoriesCS"/> <concept> <code value="Category0"/> <display value="Category 0 (Incomplete)"/> </concept> <concept> <code value="Category2"/> <display value="Category 2 (Benign)"/> </concept> <concept> <code value="Category3"/> <display value="Category 3 (Probably Benign)"/> </concept> <concept> <code value="Category4"/> <display value="Category 4 (Suspicious)"/> </concept> <concept> <code value="Category4A"/> <display value="Category 4A (Low suspicion)"/> </concept> <concept> <code value="Category4B"/> <display value="Category 4B (Moderate suspicion)"/> </concept> <concept> <code value="Category4C"/> <display value="Category 4C (High suspicion)"/> </concept> <concept> <code value="Category5"/> <display value="Category 5 (Highly Suggestive of Malignancy)"/> </concept> <concept> <code value="Category6"/> <display value="Category 6 (Known Biopsy-Proven Malignancy)"/> </concept> </include> </compose> </ValueSet>